Diethylstilbestrol: Intergenerational Impact

Debate between Lisa Smart and Preet Kaur Gill

Monday 29th June 2026 Commons Chamber

[Lisa Smart (Hazel Grove) (LD)]

I am here because my constituent Helen, from Romiley, came to see me at my advice surgery on Saturday. I was waiting to raise this point until the Minister was close to ending her speech, because I want to understand what is being done and what more the Government can do to give information to people who think they may be DES daughters. Helen’s mum certainly took something during her pregnancy, but it is difficult to interpret the GP’s handwriting on the records that Helen has received. What can the Minister tell Helen and people like her who think their health conditions suggest that they are DES daughters, but who do not yet have the evidence to show that they are?

[Preet Kaur Gill]

I thank the hon. Member for her question, and pay tribute to Helen. My hon. Friend mentioned this important issue. While there may be 600 women out there, there are many, many more who just do not know—and, I am sure, grandchildren too. Not only should information be widely available on NHS websites, but women should be able to go to their GPs, and their GPs should be able to direct them to a screening service, while also taking seriously the issues that they raise. More needs to be more done in this regard, and I look forward to working with campaigners and with my hon. Friend to establish what more we can do when we identify gaps.

I pay tribute to the women I met earlier today, who are sitting in the Gallery. Hearing directly from them their powerful testimonies puts a lot of this into context for me. It is not just about reading people’s stories; it is about the lived experience of what that trauma has been like for many women, their grandchildren and so forth. I pay tribute to Clare Fletcher; Marion and Juliette; Heather and her two daughters; Liam, Charly, Anne-Marie and her daughter; and Julia. My apologies if I have missed someone’s name. Thank you so much for sharing your exposure to DES and the fact that the healthcare system did not adequately address the recognised and multigenerational adverse effects of the drug.

We have to continue to listen carefully to those affected, learn from their experiences and take every appropriate step to safeguard people, now and in the future. As someone said, this is not simply a historical medical issue; it is about women whose voices were dismissed, whose experiences were doubted and whose families continue to live with the consequences. It is just a reminder that when women say that something is wrong, we must listen. We cannot change the past, but we can ensure that their voices shape how we respond.

Question put and agreed to.